See more : The PNC Financial Services Group, Inc. (0KEF.L) Income Statement Analysis – Financial Results
Complete financial analysis of Rayont Inc. (RAYT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rayont Inc., a leading company in the Software – Application industry within the Technology sector.
You may be interested
- Erika B-Cure Laser Ltd (BCUR.TA) Income Statement Analysis – Financial Results
- Amerant Bancorp Inc. (AMTBB) Income Statement Analysis – Financial Results
- Route Mobile Limited (ROUTE.NS) Income Statement Analysis – Financial Results
- Nettlinx Limited (NETTLINX.BO) Income Statement Analysis – Financial Results
- EL FORGE LTD. (ELFORGE.BO) Income Statement Analysis – Financial Results
Rayont Inc. (RAYT)
About Rayont Inc.
Rayont Inc., through its subsidiary, THF Holdings Pty Ltd., operates as a cancer treatment and medical device company. The company was formerly known as Velt International Group Inc. Rayont Inc. was founded in 2011 and is based in Southport, Australia.
| Metric | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.84M | 186.66K | 0.00 | 23.05K | 657.84K | 1.28M | 731.82K | 613.37K | 966.23K | 178.00K | 0.00 |
| Cost of Revenue | 1.46M | 0.00 | 0.00 | 0.00 | 745.65K | 1.11M | 645.42K | 552.03K | 879.45K | 165.65K | 0.00 |
| Gross Profit | 1.38M | 186.66K | 0.00 | 23.05K | -87.81K | 170.27K | 86.40K | 61.34K | 86.78K | 12.36K | 0.00 |
| Gross Profit Ratio | 48.69% | 100.00% | 0.00% | 100.00% | -13.35% | 13.33% | 11.81% | 10.00% | 8.98% | 6.94% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 1.40K | 5.56K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 168.48K | 289.33K | 204.97K | 237.03K | 239.22K | 205.93K | 129.66K | 37.54K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.80K | 0.00 | 0.00 |
| SG&A | 2.38M | 323.93K | 1.15M | 168.48K | 289.33K | 204.97K | 237.03K | 239.22K | 207.73K | 129.66K | 37.54K |
| Other Expenses | 485.83K | 101.59K | 104.99K | -39.11K | 5.44K | 5.44K | 5.44K | 5.44K | 4.08K | 0.00 | 0.00 |
| Operating Expenses | 2.87M | 425.53K | 1.26M | 169.56K | 296.18K | 215.98K | 242.47K | 244.66K | 211.81K | 129.66K | 37.54K |
| Cost & Expenses | 4.33M | 425.53K | 1.26M | 169.56K | 1.04M | 1.32M | 887.89K | 796.69K | 1.09M | 295.31K | 37.54K |
| Interest Income | 0.00 | 10.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 615.46K | 4.12K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95.00 | 8.00 | 0.00 |
| Depreciation & Amortization | 485.83K | 115.13K | 104.99K | 1.07K | 5.44K | 5.44K | 5.44K | 5.44K | 4.08K | -8.00 | 0.00 |
| EBITDA | 1.37M | -123.73K | -1.15M | -145.44K | -377.44K | -40.29K | -150.63K | -177.89K | -120.95K | -117.31K | -37.54K |
| EBITDA Ratio | 48.26% | -66.29% | 0.00% | -631.01% | -57.38% | -3.16% | -20.58% | -29.00% | -12.52% | -65.90% | 0.00% |
| Operating Income | 884.58K | -238.86K | -1.26M | -146.51K | -383.99K | -45.71K | -156.07K | -183.33K | -133.05K | -117.31K | -37.54K |
| Operating Income Ratio | 31.15% | -127.96% | 0.00% | -635.67% | -58.37% | -3.58% | -21.33% | -29.89% | -13.77% | -65.90% | 0.00% |
| Total Other Income/Expenses | -615.46K | 9.42K | -3.04K | -39.11K | -1.11K | 22.00 | 0.00 | 0.00 | -7.92K | -8.00 | 0.00 |
| Income Before Tax | 269.13K | -229.45K | -1.26M | -185.62K | -385.10K | -45.69K | -156.07K | -183.33K | -133.05K | -117.32K | -37.54K |
| Income Before Tax Ratio | 9.48% | -122.92% | 0.00% | -805.36% | -58.54% | -3.58% | -21.33% | -29.89% | -13.77% | -65.91% | 0.00% |
| Income Tax Expense | 24.27K | 7.51K | 0.00 | 39.11K | 1.11K | -22.00 | 0.00 | 0.00 | 8.02K | 8.00 | 0.00 |
| Net Income | 244.86K | -236.95K | -1.26M | -185.62K | -385.10K | -45.69K | -156.07K | -183.33K | -133.05K | -117.32K | -37.54K |
| Net Income Ratio | 8.62% | -126.94% | 0.00% | -805.36% | -58.54% | -3.58% | -21.33% | -29.89% | -13.77% | -65.91% | 0.00% |
| EPS | 0.01 | -0.02 | -0.14 | -0.10 | -0.20 | -0.02 | -0.09 | -0.10 | -0.07 | -0.07 | -0.02 |
| EPS Diluted | 0.01 | -0.02 | -0.14 | -0.10 | -0.20 | -0.02 | -0.09 | -0.10 | -0.07 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 47.90M | 13.03M | 8.86M | 1.89M | 1.89M | 1.87M | 1.84M | 1.83M | 1.82M | 1.73M | 1.72M |
| Weighted Avg Shares Out (Dil) | 47.90M | 13.03M | 8.87M | 1.89M | 1.91M | 1.87M | 1.84M | 1.83M | 1.82M | 1.73M | 1.72M |
Beware These 7 Penny Stock Bubbles Getting Ready to Burst
The following penny stocks have built up a large bubble that is yet to burst. They are likely to burst soon due to the market decline.
Rayont Inc- RAYT- Reports 10-K/T for the Nine-Month Ending June 30, 2021, Financial Results.
Palo Alto, California, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing of alternative medicine products and services across the entire value chain, today reported financial...
Rayont Inc- RAYT- Reports Six-Month Ending March 31, 2021, Financial Results.
Palo Alto, California, May 17, 2021 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing of alternative medicine products and services across the entire value chain, today reported financial...
Rayont Names Aleem Sheikh As CEO
International healthcare company, Rayont Inc (OTC: RAYT), appointed Aleem Sheikh as President and CEO. Sheikh previously served as Managing Director and Group Chief of Staff at ACWA Power before being appointed a Director to Arizona State University.
Rayont Inc appoints Mr. Aleem Sheikh as President and CEO to position the Company for Growth.
Queensland, Australia, March 25, 2021 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing of alternative medicine products and services across the entire value chain today announces the appointment...
Source: https://incomestatements.info
Category: Stock Reports